Nuo Therapeutics Inc AURX:OTCQB

*Data is delayed | Exchange | USD
Last | 04/18/24 EDT
0.80UNCH (UNCH)
52 week range
0.40 - 2.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.80
  • 52 Week High2.50
  • 52 Week High Date04/25/23
  • 52 Week Low0.40
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap33.853M
  • Shares Out42.32M
  • 10 Day Average Volume11,840.5
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change45.45

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.80
  • 52 Week High2.50
  • 52 Week High Date04/25/23
  • 52 Week Low0.40
  • 52 Week Low Date11/01/23
  • Market Cap33.853M
  • Shares Out42.32M
  • 10 Day Average Volume11,840.5
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change45.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.08
  • P/E (TTM)-9.64
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-3.465M
  • ROE (TTM)-179.39%
  • Revenue (TTM)485,509.992
  • Gross Margin (TTM)79.93%
  • Net Margin (TTM)-716.32%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nuo Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Nuo Therapeutics, Inc. is a regenerative therapies company. The Company is focused on developing and marketing products for chronic wound care primarily within the United States. The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. Its flagship product, Aurix, is a biodynamic hematogel that uses a patient’s own platelets and plasma as a catalyst for healing. The Company’s commercial offering...
David Jorden CPA
Chief Executive Officer, Chief Financial Officer, Director
Peter Clausen Ph.D.
Chief Operating Officer, Chief Scientific Officer
Address
8285 EL RIO, SUITE 150
Houston, TX
77054
United States

Top Peers

SYMBOLLASTCHG%CHG
LUCD
Lucid Diagnostics Inc
0.7965-0.0025-0.3129%
MLSS
Milestone Scientific Inc
0.551-0.0204-3.5702%
NXGL
Nexgel Inc
2.16-0.05-2.26%
SINT
SINTX Technologies Inc
0.0418+0.0018+4.50%
NBY
NovaBay Pharmaceuticals Inc
0.0824-0.0016-1.9048%